Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)

Clinical trial NCT07756840 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07756840
Sponsor: National Cancer Institute (NCI)
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Recurrent Papillomatosis (RRP)Human Papillomavirus (HPV)Papillomavirus Infection Laryngeal Diseases Tracheal Diseases Respiratory Tract Neoplasm

Start date: 2026-08-26
Primary completion: 2029-07-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.